This means that even twice-daily dosing leaves long windows without measurable peptide
Notably, a prescription that identifies only a patients name and drug product formulation is not sufficient to establish that the prescriber made the determination that the formulation would produce a significant difference from the commercially available drug product. According to the guidance, appropriate justification and documentation might include the following: No Dye X, patient allergy (if the comparable drug contains the dye) Liquid form, patient cant swallow tablet (if the comparable drug is a tablet) 6 mg, patient needs higher dose (if the comparable drug is only available in 5 mg dose)
All subQ
Lustig R, Greenway F, Velasquez P, Heimburger D, Schumacher D, Smith D, Smith W, Soler N, Zhu W, Hedrick J, Hohneker J: Weight loss in obese adults with insulin hypersecretion treated with Sandostatin LAR Depot
Sterile water lacks the preservative (benzyl alcohol) that prevents bacterial growth
Some individuals might benefit from switching to a medication that targets both weight loss and the management of another health condition